Karla Plevová, Ph.D.

Staff Scientist

Contact

Email:
Phone: +420 54949 5314, +420 532 234 396
Research group: Medical Genomics - Šárka Pospíšilová
Workplace:

20. Nov. 2014

The Scientist Karla Plevová Receives the Award of the Minister of Education

For her excellent results during her doctoral programme in the field of oncology, Karla Plevová from CEITEC MU received the Award of the Minister of Education, Youth and Sports for excellent students and graduates in study programmes. The award…

2018

2017

2016

2015

2014

  • Shugay, M; Britanova, OV; Merzlyak, EM; Turchaninova, MA; Mamedov, IZ; Tuganbaev, TR; Bolotin, DA; Staroverov, DB; Putintseva, EV; Plevova, K; Linnemann, C; Shagin, D; Pospisilova, S; Lukyanov, S; Schumacher, TN; Chudakov, DM, 2014: Towards error-free profiling of immune repertoires. NATURE METHODS 11(6), p. 653 - +, doi: 10.1038/NMETH.2960
  • Xochelli, A; Kavakiotis, I; Agathangelidis, A; Kienle, D; Davis, Z; Yan, XJ; Shanafelt, T; Boudjogra, M; Plevova, K; Chatzouli, M; Pedersen, LB; Veronese, S; Facco, M; Moreno, D; Chu, CC; Giudicelli, V; Panagiotidis, P; Vlahavas, I; Anagnostopoulos, A; Maglaveras, N; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Lefranc, MP; Chiorazzi, N; Oscier, D; Jelinek, DF; Stilgenbauer, S; Belessi, C; Ghia, P; Davi, F; Rosenquist, R; Darzentas, N; Chouvarda, I; Sutton, LA; Hadzidimitriou, A; Stamatopoulos, K, 2014: Charting Unique Signatures of Somatic Hypermutation Amongst Chronic Lymphocytic Leukemia Patients Expressing IGHV4-34 Clonotypic B Cell Receptors. BLOOD 124(21)
  • Baliakas, P; Hadzidimitriou, A; Sutton, LA; Minga, E; Agathangelidis, A; Tsanousa, A; Scarfo, L; Davis, Z; Yan, J; Shanafelt, TD; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjoghra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, AC; Mansouri, L; Smedby, KE; Pedersen, L; Moreno, D; van Lom, K; Giudicelli, V; Francova, H; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Rosenquist, R; Ghia, P; Stamatopoulos, K, 2014: Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia. BLOOD 124(21)
  • Baliakas, P; Hadzidimitriou, A; Sutton, LA; Minga, E; Agathangelidis, A; Nichelatti, M; Tsanousa, A; Scarfo, L; Davis, Z; Yan, XJ; Shanafelt, T; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjogra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, A; Mansouri, L; Smedby, KE; Pedersen, LB; Van Lom, K; Giudicelli, V; Francova, HS; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Rosenquist, R; Ghia, P; Stamatopoulos, K, 2014: Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. LANCET HAEMATOLOGY 1(2), p. E74 - E84
  • CEITEC - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2015
  • Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development (NS10439), Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011
  • Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia (3SGA5792), Jihomoravský kraj, 2013 - 2016
  • Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies (MSM0021622430), Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
  • Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response (NT11218), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
  • Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases (GAP301/10/0590), Czech Science Foundation - Standard Grants, 2010 - 2012
  • NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (306242), Evropská unie, 2012 - 2015
  • SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny (CZ.1.07/2.3.00/20.0045), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
  • Real-time PCR soupravy pro diagnostiku v onkologii (FR-TI2/254), Ministerstvo průmyslu a obchodu ČR, 2010 - 2013